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Figure S1. Correct cleavage by  recombinant PfSUB1 of internally quenched 
peptide Abz-LVSADNIDIQ-EDDnp 
RP-HPLC chromatogram showing fractionation of Abz-LVSADNIDIQ-EDDnp after partial 
hydrolysis with recombinant PfSUB1 (rPfSUB1). The identities of the three main peaks, 
including their predicted and measured masses as determined by electrospray mass 
spectrometry, are indicated. 
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Figure S2. Primary processing sites within MSP1 and the associated peripheral 
membrane proteins MSP6 and MSP7 
For clarity, fragments are not drawn to scale. The MSP183-MSP130 junction in the FCB-1 
allelic form of MSP1, and the precise position of an additional processing site within the 
3D7 form of MSP183, indicated by question marks, have not been previously determined, 
but are established in this study (see main manuscript text and below). The MSP636 
cleavage site in the FCB-1 form of this protein, also indicated by a question mark, is 
unknown. For references see Table 1. 
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Figure S3. Proteolytic processing of recombinant full-length MSP1 of both allelic 
forms by rPfSUB1 
Coomassie stained gels showing a time course of digestion of recombinant 3D7 and 
FCB-1 type MSP1 (MSP-1D and MSP-1F respectively) by rPfSUB1. In both cases the 
proteins were converted to a limited number of stable major fragments. 
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Figure S4. Positional conservation of the MSP183-MSP130 junction in the two major 
allelic forms of P. falciparum MSP1 
Clustal alignment of partial predicted P. falciparum primary MSP1 sequences spanning 
the junction between MSP183 (green) and MSP130 (yellow). Sequences were obtained 
from PlasmoDB (3D7 type, PlasmoDB ID PFI1475w) or from NCBI (FCB-1 type, 
accession no. P04932). Numbering is according to each sequence. The experimentally-
determined processing sites are indicated by a downward-pointing arrow, with P1 and 
P1´ residues shown in red. Gaps introduced to improve the alignment are shown by 
hyphens. Positions of sequence identity are indicated by asterisks. 
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Figure S5. Correct cleavage by rPfSUB1 of synthetic peptides based on MSP 
processing sites 
RP-HPLC chromatograms showing a time course of digestion by rPfSUB1 of a mixture 
of decapeptides pepMSP1_30/38_3D7 (Ac-QITGTSSTSS, based on sequence flanking 
the junction between 3D7 MSP130 and MSP138) and SERA6st1 (Ac-KVKAQDDFNP). 
Both peptides were cleaved at a single internal bond to produce two products of the 
expected masses, as determined by mass spectrometry (peak identities are indicated). 
One highly polar cleavage product (NH2-SSTSS-OH from pepMSP1_30/38_3D7) was 
not retained by the RP-HPLC column but eluted in the column flow-though. Although the 
starting concentrations of both peptides were equal, SERA6st1 was cleaved much more 
rapidly than pepMSP1_30/38_3D7. 
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Figure S6. Different cleavage efficiencies of peptides based on SERA4 site 1 and 
SERA6 site 1 processing sites.  
Analytical RP-HPLC chromatograms showing a time course of partial digestion of a 
mixture of decapeptides SERA4st1 (Ac-KITAQDDEES) and SERA6st1 (Ac-
KVKAQDDFNP) with rPfSUB1. Both peptides were cleaved by rPfSUB1 only at a single 
internal bond to produce products of the expected masses, as determined by mass 
spectrometry (peak identities are indicated). The relatively polar C-terminal cleavage 
products (NH2-DDEES-OH from SERA4st1 and NH2-DDFNP-OH from SERA6st1) were 
not retained by the RP-HPLC column but eluted in the column flow-though. Note that, 
although the starting concentrations of both peptides in the mixture were equal, the initial 
rate of cleavage of SERA4st1 was much greater than that of SERA6st1. 
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Figure S7. Sequence logo depicting the substrate preference of PfSUB1 based on 
SERA and MSP processing sites 
Graphical representation of a multiple sequence alignment (in single-letter code) of the 
P5 to P5´ residues flanking known and predicted PfSUB1 cleavage sites within SERA5 
(sites 1, 2 and 3), SERA4 and SERA6 (predicted sites 1 and 2), and all the MSP1, MSP6 
and MSP7 sequences investigated in this study (a total of 17 different sequences). The 
overall height of each stack of residues indicates the degree of sequence conservation 
at that position, while the height of each residue within the stack indicates the relative 
frequency of that amino acid residue at that position. Residues are colour-coded 
according to the chemical nature of their side-chains (red, acidic [D,E]; blue, basic 
[K,R,H]; green, aliphatic [L,V,I]; black, small [G,A]; purple, non-polar, non-aliphatic 
[W,F,M,P]; orange, uncharged polar [S,T,Y,N,Q]). The scissile bond is indicated by an 
arrow. The figure was produced using the WebLogo website at 
http://weblogo.berkeley.edu/logo.cgi and further annotated with Adobe Photoshop. 
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Figure S8. SDS PAGE analysis of purified PfSUB1 and PfSUB2 prodomain. 
Coomassie-stained SDS PAGE gel of purified recombinant PfSUB1 and PfSUB2 
prodomain (~16 pmol of each), produced and quantified as described in Materials and 
Methods. The left-hand lane contains molecular mass markers (masses indicated in 
kDa). 
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Table S1. Correct cleavage by rPfSUB1 of synthetic decapeptides based on MSP1, 
MSP6 and MSP7 primary processing sites  
Peptide name Peptide 
sequencea
Digestion 
product  
identifiedb
Predicted 
m/z 
Measured 
m/z 
     
pepMSP1_83/30_3D7 Ac-PLVAASETTE Ac-PLVAA 512.30 512.30 
 
pepMSP1_30/38_3D7 Ac-QITGTSSTSS Ac-QITGT 561.28 560.80 
 
pepMSP1_30/38_FCB Ac-EVSANDDTSH Ac-EVSAN 561.25 561.30 
 
pepMSP1_38/42_3D7 Ac-VVTGEAISVT Ac-VVTGE 546.27 546.24 
 
pepMSP6_36 Ac-VVQANSETNK Ac-VVQAN 572.30 572.26 
 
pepMSP7_22 Ac-KVKAQSETDT Ac-KVKAQ 615.38 615.40 
 
 
a See Table 1 (main paper) for the details of predicted MSP processing sites and 
relevant references. 
b Digestion products were fractionated by RP-HPLC and identified by electrospray mass 
spectrometry. Note that in most cases the RP-HPLC column did not retain the highly 
polar C-terminal cleavage products (which eluted in the column flow-through), allowing 
identification only of the N-terminal product of cleavage.  
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Table S2. Protease inhibitors used to pre-treat schizonts used for MSP processing 
assays 
Inhibitor Inhibitor type,  
target protease class 
Concentration 
used (final) 
4-(2-aminoethyl) benzenesulfonyl 
fluoride (AEBSF) 
Irreversible, serine  1 mM  
Antipain Reversible, cysteine/serine  10 μg ml-1  
3,4-dichloroisocoumarin (DCI)a Irreversible, serine  10 μM  
E64 Irreversible, cysteine  10 μM  
EDTA Divalent cation chelator, many 5 mM  
EGTA Calcium chelator, many 5 mM 
Leupeptin Reversible, cysteine/serine 10 μg ml-1  
Pepstatin A Reversible, aspartic 1 μM  
para-hydroxy mercuribenzoate 
(pHMB) 
Irreversible, cysteine/serine 1 mM  
Phenylmethyl sulfonyl fluoride 
(PMSF) 
Irreversible, serine 1 mM  
N-tosyl-L-lysine 
chloromethylketone (TLCK) 
Irreversible, serine 10 μM  
N-tosyl-L-phenylalanine 
chloromethylketone (TPCK) 
Irreversible, serine 10 μM  
 
a Of the inhibitors listed here, PfSUB1 is substantially sensitive only to DCI, EDTA, 
EGTA and pHMB (Withers-Martinez et al., 2002) and K. Koussis and M. Blackman, 
unpublished data) 
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Table S3. Peptides identified by MALDI-TOF analysis of MSP183 tryptic digestsa
Peptide sequence Residue  
numbers 
Calculated 
m/z 
Observed 
m/z 
Error +/- 
ppm 
NYLFTIK 143-149 897.496 898.466 -42.5 
LNFYFDLLR 190-198 1199.634 1200.652 8.8 
ANELDVLK 220-227 900.492 901.516 18.1 
ANELDVLKK 220-228 1028.587 1029.554 -38.9 
KLVFGYR 228-234 881.512 882.518 -2.4 
LVFGYR 229-234 753.417 754.461 48.2 
TTIANINELIEGSKK 256-270 1629.894 1630.910 5.5 
LYQAQYDLSIYNK 287-299 1617.804 1618.819 4.5 
QLEEAHNLISVLEKR 300-314 1777.969 1779.007 17.1 
RIDTLK 314-319 744.449 745.476 25.6 
FNIDSLFTDPLELEYYLR 373-390 2247.110 2248.199 36.2 
VDVTPKSQDPTK 396-407 1313.683 1314.691 0.5 
IITDNKER 458-465 987.535 988.536 -6.9 
DVVDKIFSAR 523-532 1148.619 1149.623 -2.9 
YTYNVEK 533-539 915.434 916.422 -21.5 
ALSYLEDYSLRK 562-573 1456.756 1457.806 28.6 
DFNHYYTLKTGLLEADIK 579-595 2027.000 2028.079 35.3 
IEDLRK 643-648 772.444 773.467 19.1 
KIELFLK 648-654 889.564 890.534 -42.5 
 
a All predicted tryptic peptide sequences are based on the 3D7 MSP1 sequence 
(PlasmoDB ID PFI1475w). 
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